TOP TIERMARKET NEWSWIRE
News & sentiment

IONIS PHARMACEUTICAL (IONS) — News & AI sentiment

IONIS PHARMACEUTICAL (IONS) news roundup. 8 stories in the last 24 hours, 12 in the past week, 39 over 30 days. Average 24-hour sentiment is 55.1/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 13 sales totalling $20.0M — net selling of $20.0M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
8
avg sentiment 55.1/100
7d stories
12
avg sentiment 53/100
30d stories
39
avg sentiment 46/100
Insider net (90d)
$20.0M
0 buys · 13 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on IONS

13h ago
13h ago
15h ago
Why is Ionis Pharmaceuticals stock climbing today?
Investing.com Markets50 · neutralgeneral
20h ago
20h ago
20h ago
21h ago
21h ago
Ionis Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
2d ago
7d ago
Canaccord reiterates Ionis stock rating on Tryngolza advantage
Investing.com Analyst Ratings56 · neutralanalyst
7d ago
H.C. Wainwright reiterates Ionis Pharmaceuticals stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
7d ago
Guggenheim cuts Ionis stock price target on Tryngolza sales outlook
Investing.com Analyst Ratings38 · neutralanalyst
Jul 21
Jul 18
Cathie Wood Just Bet Big on This Biotech Stock
The Motley Fool58 · neutralanalyst
Jul 18
Jul 16
Jul 14
Jul 14
Jul 13
Jul 13
Jul 12
Jul 12
Jul 10
Jul 10
Jul 10
Open IONS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →